Suzhou Basecare Medical Corporation Limited (2170.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap456.97M
Enterprise Value381.26M
P/E Ratio-1.69
PEG Ratio-0.06
Price/Sales Ratio1.14
Price/Book Ratio0.34
Enterprise/Revenue1.02
Enterprise/EBITDA-2.66

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.67
Operating Margin-0.64
AD

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.19

Income Statement

Revenue233.27M
Revenue/Share0.95
Gross Profit123.61M
EBITDA-166.99M
Net Income-223.46M
Diluted EPS-0.82

Balance Sheet

Total Cash378.43M
Total Cash/Share1.38
Total Debt342.35M
Total Debt/Equity0.4
Current Ratio3.9
Book Value Per Share3.16

Price History

52-Week Change-58.66
52-Week High3.21
52-Week Low1.2
Moving Average 50 Days1.37
Moving Average 200 Days1.69

Statistics

Average Volume48,453
Shares Outstanding273.53M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD